Generics power Brazilian pharma
Brazil actively encourages new entrants into its generic market by offering preferential purchase options in public tenders and special financial investment conditions through state finance organisations
Indian drug majors go samba
The Brazil pharma market is valued at around USD 13.4 billion with a growth rate of 29 per cent, according to the IMS report on April 2008.
Bafna ties up with Biocon to enter Brazil
The Chennai-based Bafna Pharmaceutical Ltd is entering into a marketing tie up with the Bangalore-based Biocon Ltd for supplying cancer drugs,
Strides eyes OTC & branded generics pie in Brazil
Strides Arcolab, one of India's leading integrated manufacturer and exporter of finished pharmaceutical dosage forms - both branded and generic, is planning to expand its range of products in the over-the-counter (OTC) segment in Brazil
Hyderabad firms set sight on Brazil
Brazil is the fifth largest export destination for the Indian companies. In 2006-07 financial year, exports to Brazil accounted at Rs 745 crore or US $182 million.
PAM India wins the best capsule filling machinery supplier award
The pharma companies in Brazil honoured Pam India, a member of ACG Worldwide, and their agent Almapal with Quality Febrafarma Award, the most prestigious award for the best capsule filling machinery supplier.
New IP challenges in Brazilian law`
Brazil, for a long time, was considered a nation where the intellectual property (IP) holders were facing problems to protect their rights.
Brazil bio: From imitators to innovators
New Brazilian products emerge for local health needs; same trend is seen also in emerging markets of India and China. Brazil is in the midst of a transition from imitator to innovator in health-related products,
Healthcare in transition
The Brazilian economy is growing at a faster pace. The strength of grain prices will boost the economy, while with the easy monetary policy,
Bal Pharma on Latin American expansion spree
The Bangalore-based Bal Pharma, a leading player in the active pharmaceutical ingredients (APIs) and finished formulations, is now gearing up to increase its presence in the Latin American region.
Brazil shines as western markets stall
Pharmaceutical companies are expected to radically change their practices when it comes to tackling emerging markets such as Brazil, China, India and Russia, according to IMS.
Copyright © Saffron Media Pvt. Ltd.